Antares Pharma Profit Margin 2006-2018 | ATRS

Current and historical gross margin, operating margin and net profit margin for Antares Pharma (ATRS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Antares Pharma net profit margin as of December 31, 2018 is -10.25%.
Antares Pharma Annual Profit Margins
Antares Pharma Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.443B $0.064B
Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes its needle-free injector systems for the delivery of insulin and growth hormone in over 20 countries and an estradiol transdermal patch for hormone replacement therapy.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $62.557B 20.78
Align Technology (ALGN) United States $23.765B 64.16
McKesson (MCK) United States $22.123B 8.61
AmerisourceBergen (ABC) United States $15.640B 11.35
Laboratory Of America Holdings (LH) United States $15.193B 13.97
Cooper (COO) United States $13.946B 24.33
Cardinal Health (CAH) United States $13.882B 9.35
DENTSPLY SIRONA (XRAY) United States $11.277B 25.08
Henry Schein (HSIC) United States $9.593B 15.50
West Pharmaceutical Services (WST) United States $8.495B 41.00
Merit Medical Systems (MMSI) United States $3.106B 32.29
CONMED (CNMD) United States $2.259B 36.04
Patterson (PDCO) United States $2.062B 16.29
Atrion (ATRI) United States $1.631B 47.87
STAAR Surgical (STAA) United States $1.380B 115.63
Invacare (IVC) United States $0.247B 0.00
Lifevantage (LFVN) United States $0.169B 22.79
Pro-Dex (PDEX) United States $0.067B 30.66
Endologix (ELGX) United States $0.061B 0.00
Biolase (BIOL) United States $0.046B 0.00
Retractable Technologies (RVP) United States $0.023B 0.00
Milestone Scientific (MLSS) United States $0.018B 0.00